Moderna wins EU contract for RSV vaccine supply
4 Articles
4 Articles
The mRESVIA vaccine protects against lung diseases such as bronchitis and pneumonia. Although most people recover at the end of a week, the virus can cause serious illness and death in risk groups.
Moderna wins EU contract for RSV vaccine supply
July 9 (Reuters) - Moderna said on Thursday it has secured a European Commission contract to supply its respiratory syncytial virus vaccine to six countries in the region. Here are the details: • The agreement gives the participating countries
The European Commission has today signed a joint procurement framework contract with Modern Pharmaceuticals of up to 24 million doses of mRNA vaccine against RSV (Respiratory Sencital Virus), with no minimum number of doses to be purchased.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium




